Atlas Trials

Viral Inhibition in Children for Treatment of RSV

Clinical trial NCT02654171 · COMPLETED

Trial details

NCT number
NCT02654171
Sponsor
Shanghai Ark Biopharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Start date
2016-05-27
Primary completion
2019-03-31
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.